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INTRODUCTION
According to the 2016 global status report, there were
40.5 million deaths due to non communicable diseases,
and about 31.5 million occurred in low- and middle-
income countries.1  Cardiovascular diseases accounted
for 44% (17.9 million) of  the total NCDs mortality.
Hypertension is an important modifiable risk factor
for cerebrovascular, renal and cardiovascular diseases.
Hypertension affects about 44% of  Western Europe
and 28% of the United States population.2,3 The overall
hospital-based prevalence is about 10% to 15%, higher
prevalence rates have been reported in middle-income
urban and rural areas.4 Despite availability of  effective
treatment for hypertension, treatment to target BP is a
universal problem in both developing and developed
countries.
Uncontrolled BP is responsible for 62% of death from
cerebrovascular diseases (CVD) and 49% of death
from Ischemic Heart Disease (IHD). These increased
risks are present in individuals ranging from 40 to 89
years. For every 20 mmHg systolic or 10 mmHg
diastolic increase in B.P, there is doubling of  mortality
from both IHD and CVD.3 The Higher the BP the
greater the chance of heart attack, Heart Failure (HF),
Stroke and kidney diseases. According to the National
Health and Nutrition Examination survey (NHANES)
between the year 1999 to 2000 about 34% of
Hypertensive Americans achieved controlled blood
pressure (less than 140/90mmHg).2,3 Mansia G et al
reviewed 2775 hypertensives aged 60.6±16.1 years
followed up in 131 specialist centers in Italy and found
that only 37.5% achieved optimal blood pressure
(defined according to ESH/ESC 2003 guideline as
BP less than 140/90mmHg).5 In an extensive review
of 8001 hypertensive patients in Japan, Nakado K et
al observed achievement rate for treatment goals (as
defined by JSH 2014) of 60.2% among young and
early phase elderly without Diabetes and chronic kidney
disease (CKD).6
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ABSTRACT
Background: High blood pressure is an independent risk factor for
cerebrovascular, renal and cardiovascular disease. According to World Health
Organization treatment to target Blood Pressure (BP) of <140/90 mmHg has
been associated with decrease in morbidity and mortality. Despite this BP
control has been very poor even in developed economies.
Objective: We set to assess level of  BP control among hypertensive patients on
treatment in Dutse, Jigawa state, and to identify treatable causes of failure to
achieve target for better management.
Methods: It is a cross sectional study of all hypertensives for more than one
year attending medical out patients clinic who have consented.  An interviewer
administered questionnaire was used to obtain information from the patients.
Results: A total of 123 patients of which 45% were females with mean age,
duration of hypertension of 51.9 and 5.9 years respectively and BMI of 40.9Kg/
m2. Eighty-three per cent, 91% and 94% were aware of salt restriction, cessation
of  smoking and alcohol moderation as lifestyle modifications respectively.
The mean Systolic and Diastolic BP were 142mmHg and 86mmHg respectively.
Fifty-two per cent were on two drugs combination including a diuretic while
4.87% were on three drugs or more. Less than a third (27.6%) had their BP
controlled at <140/90mmHg. There was no significant difference in the
demographic and clinical data between patients with controlled and
uncontrolled BP.
Conclusion: This study found that control of  BP is still poor in our setting.
This could be due to physician inertia in the treatment, use of inappropriate
combination of anti hypertensives or failure to reinforce lifestyle modifications.
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In a community survey conducted between October
and December 2015 in a town of Aksum northern
Ethiopia, Teklay AG et al studied 521 patients and
found a control rate of 18.2%.7 In an urban hospital
in Nairobi Kenya Achieng’ and colleagues studied 575
hypertensives attending outpatient clinic and found a
control rate of 24% which they attributed largely to
non-adherence.8 In Ghana a community survey
conducted between June 2001 and June 2002 showed
that only 22% of the respondents were aware of their
hypertension status out of which 11.3% were on
treatment with only 2.8% having controlled BP.9In a
clinic-based assessment of  BP control in Port Harcourt,
Nigeria, Akpa MR and colleagues found a control rate
of 33.3% among 207 hypertensive/diabetics reviewed
attending cardiology clinic.10 A control rate of  34.5%
was found by Igbis et al among 200 randomly selected
patients attending Hypertension clinic in Kano.11
This study was conducted to assess the level of blood
pressure control, pattern of anti- hypertensive
prescription and to determine factors that affect blood
pressure control in Rasheed Shekoni Specialist hospital
(RSSH Dutse), Northwest Nigeria.
MATERIALS AND METHODS
This is a cross sectional study of Hypertensive patients
attending Cardiology clinic of  Rasheed Shekoni
Specialist Hospital (RSSH) Dutse, Jigawa state in North
West Nigeria. It is a state-owned tertiary health
institution that is a major referral center from all parts
of  Jigawa state, some parts of  Kano, Bauchi, yobe
states and occasionally from Niger republic. The study
was conducted from 2nd May 2016 to 2nd November
2016.
The study participants were all patients attending the
cardiology clinic of  RSSH Dutse who were receiving
treatment for hypertension. Patients who gave
informed consent were recruited consecutively as
subjects. Patients who refused consent, or admitted to
non-compliance with anti hypertensives were excluded
from the study. Subjects were seen at least three times
during the course of  the study.
Using a structured questionnaire, biodata, as well
duration of hypertension, circumstances leading to the
diagnosis and current anti-hypertensive medications
were recorded. Likewise, complications of
Hypertension such as Heart failure, retinopathy,
cerebrovascular disease, nephropathy and
encephalopathy were also recorded.  Knowledge of
lifestyle modification and its application were also
recorded. Height was measured to the nearest meter
with a stadiometer barefooted while weight was
measured in kilogram using a standard weighing scale
with light clothing. Body mass index (BMI) was
calculated as weight (Kg) divided by the square of the
height (m) as defined by world health organization
(WHO).12
Blood pressure was measured during first visit with
an Accouson’s mercury sphygmomanometer with a
standard cuff size (12-13cm wide and 35cm long) on
both arms after the subject has rested for at least 5
minutes. The cuff  was maintained at heart level and
Korotkoff phase I and V were used as the systolic
and diastolic BP respectively.13 The arm with the higher
reading was used subsequently. On each visit 2 BP
measurements separated by at least 2 minutes were
taken and the average used. Control was considered
adequate when the  BP based on the JNC 8 criteria
was less than or equals 140/80 mmHg.3 Five milliliter
(5ml) of blood was collected in the fasting state for
the estimation of fasting blood glucose, lipid profile
and electrolytes, creatinine and urea. Hyperglycemia
was defined according to WHO criteria14, while lipid
abnormalities were defined based on the NCEP
criteria.15 Urine was also collected for urinalysis.
Proteinuria, and hematuria were graded according to
combi-9 urine dipstick test and proteinuria was as 1+
(300mg/L), 2+ (1.5g/L), 3+ (3g/L) and 4+ (20g/L)
and hematuria defined as >1+ blood.
Data was analyzed using statistical package for social
sciences version 20 (SPSS V20), numerical data were
reported as means ±SD, while student t-test was used
to compare means. Pearson correlation was used to
compare relationship between variables and multiple
regression analysis was applied to identify independent
predictors of uncontrolled hypertension. Chi square
test was used to compare categorical variables. A P
value of <0.05 was considered statistical significance.
Ethical approval was obtained from the ethics
committee of RSSH Dutse and each participant gave
an informed consent after proper explanation of  the
study.
RESULT
A total of 123 hypertensives were seen during the study
period. Fifty five (44.7%) were males and 68 (55.3%)
were females, with a female to male ratio of 1.2 to 1,
table 1 summarizes the demographic and clinical
characteristics of  the respondents. The mean age of
the respondents was 51.99(±12.49) years with a range
from 25 to 85 years. Male respondents were statistically
older than females (P =0.03). The mean duration of
hypertension was 5.9 (±5.1) years with a range from 1
year to 30 years. Twenty nine (23.6%) were diagnosed
following routine medical check, 37 (30.1%) were
diagnosed secondary to persistent headache while
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12.2%, 8.1% and 4.1% were diagnosed following
pregnancy, heart failure and stroke respectively.
Thirty-two (26%) of  the patients have one form of
hypertensive complication, with heart failure (12.2%),
retinopathy (4.9%) and encephalopathy (4.1%) being
the most common. Proportion of patients with
knowledge of lifestyle modification was 83.7% for
reduced salt intake, 51.2% for exercise, 94.3% for
alcohol moderation, 91.2% for smoking abstinence
and 27.6% for analgesic usage. About half of the
patients (56.1%) have family history of Hypertension
and it attains statistical significance in the males
(P=0.009). The mean BMI of the respondents was
40.9±28.6 Kg/m2, with 40 (32.5%) having normal
BMI, 28 (22.8%) were overweight, 16 (13%), 10
(8.1%) and 28 (22.8%) have class I, II and II obesity
respectively. The mean fasting blood sugar was
5.1±1.3mmol/L with thirty five (28.5%) of the subjects
being diabetic, the mean serum total cholesterol was
4.3±1.05mmol/L and mean serum uric acid
411±118µmol/L. Male respondents have statistically
significant higher serum creatinine (P=0.004).
Majority of the respondents were on two drugs
combination 64 (52.03%), with ACE inhibitor +
Diuretic been more commonly prescribed, while 51
(41.4%) were on 3 drugs combination, with ACE I
+CCB + Diuretic been prescribed in about a quarter
of the patients (25.2%), 6 (4.87%) of the subjects were
on four drugs combination and 2 patients were on
single agent, 34 (27.6%) and 15 (12.2%) were on anti-
platelets and statins respectively. The mean systolic and
diastolic BP was 142.75±20 and 86.1±12mmHg
respectively. There was no statistically significant
correlation between SBP and fasting blood sugar
(P=0.31), BMI (P=0.9), and duration of hypertension
(P=0.41), however there was positive correlation
between SBP and advancing Age (P=0.005). There
was a positive correlation between DBP and serum
uric acid (P=0.05).
The proportion of patient with controlled blood
pressure (<140 over 90 mmHg) was 34 (27.6%) while
89 (72.4%) had uncontrolled blood pressure. There
was a trend toward poor blood pressure control with
increasing age although the difference was not
statistically significant (P=0.06), there was no significant
difference in the demographic and clinical characteristic
between patients with controlled blood pressure and
those whose blood pressure was uncontrolled.
Uncontrolled BP was seen more frequently in subjects
Variables Male (N=55) Female (N=68) P Value
Age (years) 54.58±12.43 49.9±12.23 0.03
Duration of Hypertension (years) 4.96±5.04 6.71±5.07 0.06
Systolic Blood Pressure (mmHg) 143.56±17.9 142.09±21.74 0.68
Serum Creatinine (µmol/L) 166.8±103.97 119.54±68.53 0.004
















































Table 1: Showing demographic and clinical features of  the subjects.
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on one or two antihypertensive drugs, those on ACE-
I compared to CCB and among subjects with other
co morbidities such as retinopathy, heart disease and
obesity. In patients on three antihypertensive drugs the
BP was controlled in those on combinations containing
a diuretics and/or CCB. Among the patients with
uncontrolled blood pressure, 48 (53.9%) had stage 1
hypertension while 41 (46.1) had stage 2 hypertension.
DISCUSSION
This study was conducted to assess the level of blood
pressure control and associated risk factors among
hypertensives who were regular on follow-up for at
least one year in a semi urban town. The sex
distribution showed a female predominance of 55.3%
which is similar to that reported from Northern
Ethiopia,7 Nairobi,8  and Kano,11 this could be
attributed to a better health seeking behavior of the
female as well as the higher female population in the
country.16  The mean age of  the patients was 51.99
years similar to that reported from other studies,7,8,10,11
however it was lower than that reported from Italy.5
This could be due to longer life expectancy and ageing
population in Europe.
Our study revealed a BP control rate of 27.6% which
is far below the recommended target by WHO of
50%.17 Nonetheless, this is similar to reported control
rate of 20.4% to 33.3% in other parts of the
country.11,18,19,20 Similarly, in a systematic review of  the
Variables Control (N=34) Uncontrolled(N=89) P value
Age (years) 55.32±14.99 50.72±11.23 0.067

















































Total cholesterol (mmol/L) 4.2±1.2 4.3±1.0 0.702
Table 2: Showing the characteristics of  patients based on control of  Blood Pressure
literature, Kayima et al found that the control rates were
uniformly low and never exceeded 45% in 38
community based cross-sectional studies from 23
African countries within 1993 to 2013.21 This suggested
that control of  BP is generally poor in Africans. In
contrast, in a study by Joffres and colleagues who
reviewed national surveys from Britain and North
America, control rate of 34%, 50% and 66%  in
England (2006), United states (2007-2010) and Canada
(2007-2009) respectively were found.22
The WHO reports that suboptimal BP control is
responsible for 62% of cerebrovascular disease and
49% of Ischemic Heart disease. 23 In addition
suboptimal BP is the single most important attributable
risk factor for death throughout the world.3 In
developed countries, the improved control of
hypertension has led to considerable reduction in
overall morbidity and mortality over the last fifty
years.24 In addition  suboptimal BP can accelerate the
progression chronic complications such as
Nephropathy, and retinopathy. Therefore in order to
decrease the current burden of uncontrolled
hypertension co-ordinated and concerted efforts are
needed. Local as well as National programs to improve
detection, treatment and control of hypertension taking
in to consideration various socio-cultural and
economic influences needs to be initiated.
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Many factors could be responsible for the poor BP
control in Africa. Genetic or environmental factors
may be involved. Adequate education is lacking in most
African countries which lead to poor health seeking
behavior. Even though more than half  of  the subjects
were aware of the beneficial effect of exercise in the
management of hypertension, the knowledge of other
forms of  lifestyle changes such as salt restrictions was
low among the subjects. In contrast, in a small
community survey in Umuahia, southeast Nigeria,
Okwonu CG et al. evaluated knowledge and practice
of lifestyle modification among 101 participants and
concluded that 87% of their patients have knowledge
of salt restriction as a measure to control hypertension,
however few patients were aware of the role of
exercise in BP control.18
Our study failed to show significant correlation between
blood pressure and certain patients’ factors, this is in
contrast to Akpa et al. that found significant negative
correlation between systolic and diastolic BP with
fasting blood sugar, total cholesterol and triglycerides.9
This may be due to the small sample size in our study
and/or other unidentified factor such concomitant use
of drugs known to increase BP (such as analgesics
that are widely abused), fake and substandard anti
hypertensives, etc. Further, our study did not identify
statistically significant risk factors that could lead to
uncontrolled BP, this is in agreement with the work of
Achieng et al.8 in Nairobi that found no significant
difference between various factors such as age, gender,
duration of hypertension and knowledge of lifestyle
modifications among patients with control or
uncontrolled BP.
The prescription pattern may also play a role, whereas
more than 90% of the patients were on diuretics, 46.2%
were on two drugs combination of a diuretic and
Angiotensin converting enzyme inhibitors (ACE-I).
This is in disagreement with the JNC 8 recommenda-
tion of the use of a calcium channel blocker (CCB)
instead of  ACE-I in black hypertensives. The presence
of other cardiovascular risk factors such as Diabetes
mellitus, obesity, dyslipidemia etc may also affect BP
control. In this study there was low usage of statins
and anti platelets whose beneficial effect   has been
well known among hypertensives.
CONCLUSION
This study found that control of BP among
hypertensive subjects is poor in our setting. In order
to achieve the recommended target for BP control it
has become pertinent on all physicians to follow
international guidelines and to strive hard in creating
more awareness among hypertensive on the need to
treat to target.
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